Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study-Reference-Cited by-同舟云学术

Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study

Published:2019-10 Issue:10 Volume:4 Page:771-780
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Bethea Emily D,Gaj Kerry,Gustafson Jenna L,Axtell Andrea,Lebeis Taylor,Schoenike Mark,Turvey Karen,Coglianese Erin,Thomas Sunu,Newton-Cheh Christopher,Ibrahim Nasrien,Carlson William,Ho Jennifer E,Shah Ravi,Nayor Matthew,Gift Thais,Shao Sarah,Dugal Amanda,Markmann James,Elias Nahel,Yeh Heidi,Andersson Karin,Pratt Daniel,Bhan Irun,Safa Kassem,Fishman Jay,Kotton Camille,Myoung Paul,Villavicencio Mauricio A,D'Alessandro David,Chung Raymond T,Lewis Gregory D

Funder

American Association for the Study of Liver Diseases

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. National data,2019

2. The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study;Durand;Ann Intern Med,2018

3. The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation;Levitsky;Am J Transplant,2017

4. Impact of hepatitis C infection on outcomes after heart transplantation;Fong;Transplantation,2009

5. Outcome of de novo hepatitis C virus infection in heart transplant recipients;Ong;Hepatology,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mid-term Waitlist and Posttransplant Outcomes With Hepatitis C-positive Donor Hearts;Transplantation;2024-09-04

2. Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey;Transplant Infectious Disease;2024-07-22

3. Expanding the Criteria for Heart Transplantation Donors: A Review of DCD, Increased Ischemic Times, HCV, HIV, and Extended Criteria Donors;The Heart Surgery Forum;2023-10-30

4. Donantes de virus de la hepatitis C positivo en receptores negativo para trasplante hepático. ¿Es posible en México?;Revista de Gastroenterología de México;2023-10

5. Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?;Revista de Gastroenterología de México (English Edition);2023-10